Kenvue Shares Tumble 10% Amid Reports on Autism Link to Tylenol Use in Pregnancy

On Friday, Kenvue's stock saw a significant decline of over 10% following revelations that Robert F. Kennedy Jr., Secretary of Health and Human Services, is expected to propose a connection between autism and the use of Tylenol during pregnancy.

Potential Impact of Upcoming HHS Report

According to the Wall Street Journal, the report anticipated from HHS later this month could detail this potential association, causing apprehension among investors.

Additionally, the same report may recommend treatment approaches involving a compound derived from folate—a vitamin known for its water solubility—that could alleviate developmental disorder symptoms in certain individuals.